Validation of a method for the quantitative determination of narcotic and psychotropic substances in urine by UHPLC–MS/MS

Objectives. To validate a new method for the quantitative determination of 31 potent and narcotic substances and their metabolites in urine that meets the requirements of ISO/IEC 17025 using a fast and highly sensitive method of chromato-mass spectrometry with a view to introducing such a method into the routine practice of the National Anti-Doping Laboratory of the Lomonosov Moscow State University (NADL MSU).

Methods. Urine samples soldered with standard solutions were analyzed using ultra high performance liquid chromatography-tandem mass spectrometry (UHPLC–MS/MS).

Results. Diagnostic precursor/ion-product pairs and collision energies were established to allow unambiguous identification of the analyzed substances. During sample preparation, hydrolysis conditions were optimized. Selectivity, linearity, limits of qualitative determination, limit of quantitative determination (established under the contract with the customer firm), matrix effect, and measurement uncertainty were defined. Systematized data grouped by classes of analytes are given in the final table.

Conclusions. The important advantages of the presented technique are the absence of complex and lengthy sample preparation, as well as the short time of the analysis method (about 10 min), which can significantly reduce duration along with labor and analysis costs. The addition of new analytes will ensure the versatility of the technique, as well as expanding its scope.

1. Buser G.L., Gerona R.R., Horowitz B.Z., Vian K.P., Troxell M.L., Hendrickson R.G., Houghton D.C., Rozansky D., Su S.W., Leman R.F. Acute kidney injury associated with smoking synthetic cannabinoid. Clin. Toxicol. (Phila). 2014 52(7):664–673. https://doi.org/10.3109/15563650.2014.932365

2. Negishi S., Nakazono Y., Iwata Y.T., Kanamori T., Tsujikawa K., Kuwayama K., Inoue H. Differentiation of regioisomeric chloroamphetamine analogs using gas chromatography–chemical ionization-tandem mass spectrometry. Forensic Toxicol. 2015;33(2):338–347. https://doi.org/10.1007/s11419-015-0280-y

3. Maresová V., Chadt J., Prikryl L. Simultaneous determination of amphetamines and amphetamine-derived designer drugs in human urine by GC-MS. Neuro Endocrinol. Lett. 2006;27(Suppl. 2):121–124.

4. Choi H., Heo S., Choe S., Yang W., Park Y., Kim E., Lee J. Simultaneous analysis of synthetic cannabinoids in the materials seized during drug trafficking using GC-MS. Anal. Bioanal. Chem. 2012;405(12):3937–3944. https://doi.org/10.1007/s00216-012-6560-z

5. Aszyk J., Kot-Wasik A. The use of HPLC-Q-TOF-MS for comprehensive screening of drugs and psychoactive substances in hair samples and several “legal highs” products. Monatsh. Chem. 2016;147:1407–1414. https://doi.org/10.1007/s00706-016-1773-z

6. Illarionova E.A., Syrovatskii I.P. Khimikotoksikologicheskii analiz psikhotropnykh lekarstvennykh preparatov: uchebnoe posobie (Chemical-toxicological analysis of psychotropic drugs. Textbook). Irkutsk: ISMU; 2021. 81 р. (in Russ.).

7. Starovoitova M.K., Minachenkova A.S., Krys’ko M.V., Slustovskaya Yu.V., Strelova O.Yu., Kuklin V.N. Comparative characteristics of enzymatic hydrolysis methods for isolating toxic substances from whole blood and hair. Sudebno-Meditsinskaya Ekspertiza. 2020;63(3):23–29 (in Russ.). https://doi.org/10.17116/sudmed20206303123

8. Mazzarino M., de la Torre X., Botrè F. A screening method for the simultaneous detection of glucocorticoids, diuretics, stimulants, anti-oestrogens, beta-adrenergic drugs and anabolic steroids in human urine by LC-ESI-MS/MS. Anal. Bioanal. Chem. 2008;392(4):681–698. https://doi.org/10.1007/s00216-008-2292-5

9. Thevis M., Thomas A., Schänzer W. Current role of LC-MS(/MS) in doping control. Anal. Bioanal. Chem. 2011;401(2):405–420. https://doi.org/10.1007/s00216-011-4859-9

10. Kim Y., Jeon M., Min H., Son J., Lee J., Kwon O.-S., Kim K.H. Development of a multi-functional concurrent assay using weak cation-exchange solid-phase extraction (WCX-SPE) and reconstitution with a diluted sample aliquot for anti-doping analysis. Rapid Commun. Mass Spectrom. 2018;32(11):897–905. https://doi.org/10.1002/rcm.8119

11. Zybin D.I., Seregin A.S., Askretkov A.D., Orlova N.V., Seregin Y.A., Prostyakova A.I., Kapustin D.V. Development and validation of a method for the determination of the specific activity of recombinant monoclonal antibody eculizumab. Fine Chem. Tech. 2020;15(2):77–85. https://doi.org/10.32362/2410-6593-2020-15-2-77-85

12. Du L., Li G., Gong W., Zhu J., Liu L., Zhu L., Liu Z. Establishment and validation of the LC-MS/MS method for the determination of lincomycin in human blood: Application to an allergy case in forensic science. J. Forensic Leg. Med. 2021;77:102094. https://doi.org/10.1016/j.jflm.2020.102094

13. Márta Z., Bobály B., Fekete J., Magda B., Imre T., Szabó P.T. Simultaneous determination of ten nonsteroidal anti-inflammatory drugs from drinking water, surface water and wastewater using micro UHPLC-MS/MS with on-line SPE system. J. Pharm. Biomed. Anal. 2018;160:99–108. https://doi.org/10.1016/j.jpba.2018.07.016